First human tests for new herpes treatment complete
NCT ID NCT06698575
Summary
This early-stage study tested the safety and how the body processes a new drug called ABI-1179. It involved 103 healthy volunteers and people with recurrent genital herpes caused by HSV-2. The main goal was to see if the drug was safe and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty Research
Kansas City, Missouri, 64114, United States
-
Canopy Clinical Wollongong
Wollongong, Australia, 2500, Australia
-
East Sydney Doctors
Darlinghurst, Australia, 2010, Australia
-
Momentum Clinical Research
Sydney, Australia, 2010, Australia
-
Momentum Kapiti
Waikanae, New Zealand, 5036, New Zealand
-
Momentum Palmerston North
Palmerston North, New Zealand, 4414, New Zealand
-
Momentum Sunshine
Melbourne, Au, 3021, Australia
-
New Zealand Clinical Research
Auckland, New Zealand, 1010, New Zealand
-
New Zealand Clinical Research
Christchurch, New Zealand, 8011, New Zealand
-
Pacific Clinical Research Network
Nelson, New Zealand, 7011, New Zealand
-
Pacific Clinical Research Network
Rotorua, New Zealand, 3010, New Zealand
-
Pacific Clinical Research Network
Upper Hutt, New Zealand, 5018, New Zealand
-
Pacific Clinical Research Network
Hamilton, New, 3200, New Zealand
-
Rochester Clinical Research
Rochester, New York, 14609, United States
-
Royal Melbourne Hospital
Parkville, Australia, 3050, Australia
-
Seattle Clinical Research Center
Seattle, Washington, 98104, United States
-
Taylor Square Private Clinic
Surry Hills, Australia, 2010, Australia
-
University of Washington Virology Research Clinic
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.